Security key
22663K107
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX)
CUSIP: 22663K107
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 104,559,713
- Total 13F value
- $3,007,383,972
- Share change
- +2,782,185
- Put/Call ratio
- 25%
- SEC-reported price per share
- $28.76
- Number of holders
- 220
- Value change
- +$75,026,414
- Number of buys
- 127
- Number of sells
- 102
- Shares outstanding
- 105,000,216
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
220
Top holders
10
CRNX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Crinetics Pharmaceuticals, Inc. SEC filings
Crinetics Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22663K107
Recent filing periods:
Ownership snapshot
Top reported holders of CRNX - Crinetics Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
13D/G
Lead comparable stake: 15%
13D/G row: FMR LLC
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
15%
VANGUARD GROUP INC
8.9%
BlackRock, Inc.
7.3%
WELLINGTON MANAGEMENT GROUP LLP
6.6%
DRIEHAUS CAPITAL MANAGEMENT LLC
5.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
13D/G
Company
|
15%
from 13D/G
|
$470,608,761
14,031,269 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
8.9%
|
$312,311,064
9,311,600 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
7.3%
|
$256,801,325
7,656,569 shares
|
— | 31 Mar 2025 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
6.6%
|
$231,137,455
6,891,397 shares
|
— | 31 Mar 2025 |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
Company
|
5.9%
|
$209,286,313
6,239,902 shares
|
— | 31 Mar 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
4.9%
|
$171,470,000
5,112,360 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
220
Shares
104,559,713
Rows available
220
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
225
Q2 2025 holders
220
Holder diff
-5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend